- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo - Abstract
February 17, 2011
Urinary and sexual disorders following localised prostate cancer management - Abstract
February 16, 2011
Focal therapy in the management of localized prostate cancer - Abstract
February 16, 2011
Long-term outcome in patients with a Gleason score ≤ 6 prostate cancer treated by radical prostatectomy - Abstract
February 16, 2011
Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens - Abstract
February 16, 2011
Long-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancer - Abstract
February 16, 2011
Gleason 6 prostate cancer in one or two biopsy cores can harbor more aggressive disease - Abstract
February 16, 2011
Prostate volume and its correlation with histopathological outcomes in prostate cancer - Abstract
February 16, 2011
Recent developments in prostate cancer biomarker research: Therapeutic implications - Abstract
February 15, 2011
High-risk clinically localised prostate cancer - Abstract
February 15, 2011
Battling prostate cancer with 5-alpha-reductase inhibitors: A Pyrrhic victory? - Abstract
February 15, 2011
Enhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated aurora kinase B inhibition - Abstract
February 15, 2011
Is a decreased serum testosterone level a risk factor for prostate cancer? A cohort study of Korean men - Abstract
February 15, 2011
The genomic complexity of primary human prostate cancer - Abstract
February 15, 2011